5 results
424B5
GYRE
Gyre Therapeutics Inc
28 Jan 21
Prospectus supplement for primary offering
4:11pm
supply chain disruptions as the ongoing COVID-19 pandemic has impacted the ability of some of our suppliers to deliver certain raw materials on a timely
424B5
GYRE
Gyre Therapeutics Inc
26 Jan 21
Prospectus supplement for primary offering
4:07pm
some supply chain disruptions as the ongoing COVID-19 pandemic has impacted the ability of some of our suppliers to deliver certain raw materials
8-K
EX-10.1
GYRE
Gyre Therapeutics Inc
15 Oct 19
Entry into a Material Definitive Agreement
2:10pm
Components in quantities sufficient to meet Client’s Firm Orders for Product, including additional quantities as necessary for efficient supply chain management
8-K
GYRE
Gyre Therapeutics Inc
26 Jan 07
Entry into a Material Definitive Agreement
12:00am
or in a timely manner, such as work stoppages, supply chain disruptions or disputes between the Company and OA or Shelco, between OA and Shelco
- Prev
- 1
- Next